相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer progression as a sequence of atavistic reversions
Charles H. Lineweaver et al.
BIOESSAYS (2021)
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth
Davide Gnocchi et al.
CHEMMEDCHEM (2021)
Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy
Davide Gnocchi et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2021)
New hypotheses for cancer generation and progression
Antonio Mazzocca et al.
MEDICAL HYPOTHESES (2021)
Reverting to single-cell biology: The predictions of the atavism theory of cancer
Kimberly J. Bussey et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2021)
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis
Ruize Gao et al.
ONCOGENESIS (2021)
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function
Davide Gnocchi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells
Maria A. Rodriguez-Hernandez et al.
CELL DEATH & DISEASE (2020)
Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer
Maria A. Rodriguez-Hernandez et al.
REDOX BIOLOGY (2020)
Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance
Zeribe Chike Nwosu et al.
EBIOMEDICINE (2020)
Development of a Novel Hanging Drop Platform for Engineering Controllable 3D Microenvironments
Chin-Yi Cho et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Dose-dependent regulation of mitochondria' function and cell death pathway by sorafenib in liver cancer cells
Maria A. Rodriguez-Hernandez et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics
Sameer Salunkhe et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2020)
Targeting Metabolic Plasticity and flexibility Dynamics for Cancer Therapy
Sarah-Maria Fendt et al.
CANCER DISCOVERY (2020)
Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
Christoph Roderburg et al.
HEPATIC ONCOLOGY (2020)
New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation
Justin L. Tan et al.
GASTROENTEROLOGY (2019)
The Systemic-Evolutionary Theory of the Origin of Cancer (SETOC): A New Interpretative Model of Cancer as a Complex Biological System
Antonio Mazzocca
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment
Pasquale Agosti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Recent developments with immunotherapy for hepatocellular carcinoma
Oliver Waidmann
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Moving the systemic evolutionary approach to cancer forward: Therapeutic implications
Antonio Mazzocca et al.
MEDICAL HYPOTHESES (2018)
Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
Masatoshi Kudo
CANCERS (2018)
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
Carolina Mendez-Blanco et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Hepatocyte Autotaxin Expression Promotes Liver Fibrosis and Cancer
Eleanna Kaffe et al.
HEPATOLOGY (2017)
Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness
Young-Kyoung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism
Jitka Soukupova et al.
SCIENTIFIC REPORTS (2017)
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition
Shigeki Nakagawa et al.
CANCER CELL (2016)
A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigm
Antonio Mazzocca et al.
MEDICAL HYPOTHESES (2016)
Lysophosphatidic Acid Receptor LPAR6 Supports the Tumorigenicity of Hepatocellular Carcinoma
Antonio Mazzocca et al.
CANCER RESEARCH (2015)
Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond
Gennaro Gadaleta-Caldarola et al.
FUTURE ONCOLOGY (2015)
Sorafenib: 10 years after the first pivotal trial
Gennaro Gadaleta-Caldarola et al.
FUTURE ONCOLOGY (2015)
Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs
Chia-Chi Hsu et al.
ONCOLOGY REPORTS (2015)
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing
Valentina Tesori et al.
SCIENTIFIC REPORTS (2015)
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
Y-C Shen et al.
BRITISH JOURNAL OF CANCER (2013)
Three-dimensional cell culture: the missing link in drug discovery
Susan Breslin et al.
DRUG DISCOVERY TODAY (2013)
Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
Angela Gauthier et al.
HEPATOLOGY RESEARCH (2013)
Tumor-Secreted Lysophostatidic Acid Accelerates Hepatocellular Carcinoma Progression by Promoting Differentiation of Peritumoral Fibroblasts in Myofibroblasts
Antonio Mazzocca et al.
HEPATOLOGY (2011)
Tight control of mitochondrial membrane potential by cytochrome c oxidase
Consiglia Pacelli et al.
MITOCHONDRION (2011)
Oligomycin-induced Bioenergetic Adaptation in Cancer Cells with Heterogeneous Bioenergetic Organization
Wenshan Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Recent advances in three-dimensional multicellular spheroid culture for biomedical research
Ruei-Zhen Lin et al.
Biotechnology Journal (2008)
The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells
Zoltan Derdak et al.
CANCER RESEARCH (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
分享论文
